Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03678883
Title 9-ING-41 in Patients With Advanced Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Actuate Therapeutics Inc.
Indications

Advanced Solid Tumor

Therapies

9-ING-41 + Carboplatin + Paclitaxel

9-ING-41 + Irinotecan

9-ING-41 + Doxorubicin

9-ING-41 + Lomustine

9-ING-41 + Carboplatin

9-ING-41 + Gemcitabine + Nab-paclitaxel

9-ING-41

9-ING-41 + Gemcitabine

Age Groups: adult | senior
Covered Countries USA | ESP


No variant requirements are available.